BECTON, DICKINSON AND COMPANY Net Income
BECTON, DICKINSON AND COMPANY (BDX) reported Net Income of $377.00 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Net Income
us-gaap:NetIncomeLoss · last filed 2026-08-06
- BECTON, DICKINSON AND COMPANY net income (loss) attributable to parent for the quarter ending 2026-06-30 was $377.00M, a 34.32% decline year-over-year.
- BECTON, DICKINSON AND COMPANY net income (loss) attributable to parent for the quarter ending 2026-03-31 was -$311.00M, a 200.97% decline year-over-year.
- BECTON, DICKINSON AND COMPANY net income (loss) attributable to parent for the quarter ending 2025-12-31 was $382.00M, a 26.07% increase year-over-year.
- BECTON, DICKINSON AND COMPANY net income (loss) attributable to parent for the quarter ending 2025-09-30 was $493.00M, a 23.25% increase year-over-year.
- BECTON, DICKINSON AND COMPANY net income (loss) attributable to parent for fiscal 2025 was $1.68B, a 1.58% decline from fiscal 2024.
- BECTON, DICKINSON AND COMPANY net income (loss) attributable to parent for fiscal 2024 was $1.71B, a 14.89% increase from fiscal 2023.
- BECTON, DICKINSON AND COMPANY net income (loss) attributable to parent for fiscal 2023 was $1.48B, a 16.58% decline from fiscal 2022.
- BECTON, DICKINSON AND COMPANY net income (loss) attributable to parent for fiscal 2022 was $1.78B, a 14.96% decline from fiscal 2021.
| Period end | Net Income (Loss) Attributable to Parent 3 month | Net Income (Loss) Attributable to Parent 6 month | Net Income (Loss) Attributable to Parent 9 month | Net Income (Loss) Attributable to Parent 12 month |
|---|---|---|---|---|
| 2026-06-30 | $377.00M 10-Q · filed 2026-08-06 | $66.00M derived: sum of 2 quarters · filed 2026-08-06 | $449.00M 10-Q · filed 2026-08-06 | $941.00M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | -$311.00M 10-Q · filed 2026-05-07 | $72.00M 10-Q · filed 2026-05-07 | $564.00M derived: sum of 3 quarters · filed 2026-05-07 | $1.14B derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $382.00M 10-Q · filed 2026-02-09 | $875.00M derived: sum of 2 quarters · filed 2026-02-09 | $1.45B derived: sum of 3 quarters · filed 2026-08-06 | $1.76B derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-09-30 | $493.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-11-25 | $1.07B derived: sum of 2 quarters · filed 2026-08-06 | $1.38B derived: sum of 3 quarters · filed 2026-08-06 | $1.68B 10-K · filed 2025-11-25 |
| 2025-06-30 | $574.00M 10-Q · filed 2026-08-06 | $882.00M derived: sum of 2 quarters · filed 2026-08-06 | $1.19B 10-Q · filed 2026-08-06 | $1.58B derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $308.00M 10-Q · filed 2026-05-07 | $611.00M 10-Q · filed 2026-05-07 | $1.01B derived: sum of 3 quarters · filed 2026-05-07 | $1.50B derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $303.00M 10-Q · filed 2026-02-09 | $703.00M derived: sum of 2 quarters · filed 2026-02-09 | $1.19B derived: sum of 3 quarters · filed 2026-02-09 | $1.73B derived: sum of 4 quarters · filed 2026-02-09 |
| 2024-09-30 | $400.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-11-25 | $887.00M derived: sum of 2 quarters · filed 2025-11-25 | $1.42B derived: sum of 3 quarters · filed 2025-11-25 | $1.71B 10-K · filed 2025-11-25 |
| 2024-06-30 | $487.00M 10-Q · filed 2025-08-07 | $1.02B derived: sum of 2 quarters · filed 2025-08-07 | $1.30B 10-Q · filed 2025-08-07 | $1.41B derived: sum of 4 quarters · filed 2025-11-25 |
| 2024-03-31 | $537.00M 10-Q · filed 2025-05-01 | $818.00M 10-Q · filed 2025-05-01 | $926.00M derived: sum of 3 quarters · filed 2025-11-25 | $1.33B derived: sum of 4 quarters · filed 2025-11-25 |
| 2023-12-31 | $281.00M 10-Q · filed 2025-02-06 | $389.00M derived: sum of 2 quarters · filed 2025-11-25 | $796.00M derived: sum of 3 quarters · filed 2025-11-25 | $1.26B derived: sum of 4 quarters · filed 2025-11-25 |
| 2023-09-30 | $108.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-11-25 | $515.00M derived: sum of 2 quarters · filed 2025-11-25 | $975.00M derived: sum of 3 quarters · filed 2025-11-25 | $1.48B 10-K · filed 2025-11-25 |
| 2023-06-30 | $407.00M 10-Q · filed 2024-08-01 | $867.00M derived: sum of 2 quarters · filed 2024-08-01 | $1.38B 10-Q · filed 2024-08-01 | $1.66B derived: sum of 4 quarters · filed 2024-11-27 |
| 2023-03-31 | $460.00M 10-Q · filed 2024-05-02 | $969.00M 10-Q · filed 2024-05-02 | $1.26B derived: sum of 3 quarters · filed 2024-11-27 | $1.62B derived: sum of 4 quarters · filed 2024-11-27 |
| 2022-12-31 | $509.00M 10-Q · filed 2024-02-01 | $797.00M derived: sum of 2 quarters · filed 2024-11-27 | $1.16B derived: sum of 3 quarters · filed 2024-11-27 | $1.61B derived: sum of 4 quarters · filed 2024-11-27 |
| 2022-09-30 | $288.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-11-27 | $648.00M derived: sum of 2 quarters · filed 2024-11-27 | $1.10B derived: sum of 3 quarters · filed 2024-11-27 | $1.78B 10-K · filed 2024-11-27 |
| 2022-06-30 | $360.00M 10-Q · filed 2023-08-03 | $814.00M derived: sum of 2 quarters · filed 2023-08-03 | $1.49B 10-Q · filed 2023-08-03 | $1.76B derived: sum of 4 quarters · filed 2023-11-21 |
| 2022-03-31 | $454.00M 10-Q · filed 2023-05-04 | $1.13B 10-Q · filed 2023-05-04 | $1.40B derived: sum of 3 quarters · filed 2023-11-21 | $1.92B derived: sum of 4 quarters · filed 2023-11-21 |
| 2021-12-31 | $677.00M 10-Q · filed 2023-02-02 | $942.00M derived: sum of 2 quarters · filed 2023-11-21 | $1.47B derived: sum of 3 quarters · filed 2023-11-21 | $1.77B derived: sum of 4 quarters · filed 2023-11-21 |
| 2021-09-30 | $265.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-11-21 | $790.00M derived: sum of 2 quarters · filed 2023-11-21 | $1.09B derived: sum of 3 quarters · filed 2023-11-21 | $2.09B 10-K · filed 2023-11-21 |
| 2021-06-30 | $525.00M 10-Q · filed 2022-08-04 | $824.00M derived: sum of 2 quarters · filed 2022-08-04 | $1.83B 10-Q · filed 2022-08-04 | $1.96B derived: sum of 4 quarters · filed 2022-08-04 |
| 2021-03-31 | $299.00M 10-Q · filed 2022-05-05 | $1.30B 10-Q · filed 2022-05-05 | $1.43B derived: sum of 3 quarters · filed 2022-05-05 | $1.72B derived: sum of 4 quarters · filed 2022-05-05 |
| 2020-12-31 | $1.00B 10-Q · filed 2022-02-03 | $1.13B derived: sum of 2 quarters · filed 2022-02-03 | $1.42B derived: sum of 3 quarters · filed 2022-02-03 | $1.60B derived: sum of 4 quarters · filed 2022-02-03 |
| 2020-09-30 | $128.00M 10-K · filed 2020-11-25 | $414.00M derived: sum of 2 quarters · filed 2021-08-05 | $597.00M derived: sum of 3 quarters · filed 2021-08-05 | $874.00M 10-K · filed 2022-11-22 |
| 2020-06-30 | $286.00M 10-Q · filed 2021-08-05 | $469.00M derived: sum of 2 quarters · filed 2021-08-05 | $746.00M 10-Q · filed 2021-08-05 | $910.00M derived: sum of 4 quarters · filed 2021-08-05 |
| 2020-03-31 | $183.00M 10-Q · filed 2021-05-06 | $461.00M 10-Q · filed 2021-05-06 | $624.00M derived: sum of 3 quarters · filed 2021-05-06 | $1.07B derived: sum of 4 quarters · filed 2021-05-06 |
| 2019-12-31 | $278.00M 10-Q · filed 2021-02-04 | $441.00M derived: sum of 2 quarters · filed 2021-02-04 | $892.00M derived: sum of 3 quarters · filed 2021-02-04 | $912.00M derived: sum of 4 quarters · filed 2021-02-04 |
| 2019-09-30 | $163.00M 10-K · filed 2020-11-25 | $614.00M derived: sum of 2 quarters · filed 2020-11-25 | $634.00M derived: sum of 3 quarters · filed 2020-11-25 | $1.23B 10-K · filed 2021-11-24 |
| 2019-06-30 | $451.00M 10-K · filed 2020-11-25 | $471.00M derived: sum of 2 quarters · filed 2020-11-25 | $1.07B 10-Q · filed 2020-08-06 | $935.00M derived: sum of 4 quarters · filed 2020-11-25 |
| 2019-03-31 | $20.00M 10-K · filed 2020-11-25 | $619.00M 10-Q · filed 2020-05-07 | $484.00M derived: sum of 3 quarters · filed 2020-11-25 | $1.08B derived: sum of 4 quarters · filed 2020-11-25 |
| 2018-12-31 | $599.00M 10-K · filed 2020-11-25 | $464.00M derived: sum of 2 quarters · filed 2020-11-25 | $1.06B derived: sum of 3 quarters · filed 2020-11-25 | $1.05B derived: sum of 4 quarters · filed 2020-11-25 |
| 2018-09-30 | -$135.00M 10-K · filed 2019-11-27 | $459.00M derived: sum of 2 quarters · filed 2019-11-27 | $447.00M derived: sum of 3 quarters · filed 2019-11-27 | $311.00M 10-K · filed 2020-11-25 |
| 2018-06-30 | $594.00M 10-K · filed 2019-11-27 | $582.00M derived: sum of 2 quarters · filed 2019-11-27 | $446.00M 10-Q · filed 2019-08-06 | $773.00M derived: sum of 4 quarters · filed 2019-11-27 |
| 2018-03-31 | -$12.00M 10-K · filed 2019-11-27 | -$148.00M 10-Q · filed 2019-05-09 | $179.00M derived: sum of 3 quarters · filed 2019-11-27 | $47.00M derived: sum of 4 quarters · filed 2019-11-27 |
| 2017-12-31 | -$136.00M 10-K · filed 2019-11-27 | $191.00M derived: sum of 2 quarters · filed 2019-11-27 | $59.00M derived: sum of 3 quarters · filed 2019-11-27 | $403.00M derived: sum of 4 quarters · filed 2019-11-27 |
| 2017-09-30 | $327.00M 10-K · filed 2018-11-21 | $195.00M derived: sum of 2 quarters · filed 2018-11-21 | $539.00M derived: sum of 3 quarters · filed 2018-11-21 | $1.10B 10-K · filed 2019-11-27 |
| 2017-06-30 | -$132.00M 10-K · filed 2018-11-21 | $212.00M derived: sum of 2 quarters · filed 2018-11-21 | $773.00M 10-Q · filed 2018-08-02 | $793.00M derived: sum of 4 quarters · filed 2018-11-21 |
| 2017-03-31 | $344.00M 10-K · filed 2018-11-21 | $905.00M 10-Q · filed 2018-05-03 | $925.00M derived: sum of 3 quarters · filed 2018-11-21 | $1.31B derived: sum of 4 quarters · filed 2018-11-21 |
| 2016-12-31 | $562.00M 10-K · filed 2018-11-21 | $581.00M derived: sum of 2 quarters · filed 2018-11-21 | $971.00M derived: sum of 3 quarters · filed 2018-11-21 | $1.31B derived: sum of 4 quarters · filed 2018-11-21 |
| 2016-09-30 | $19.00M 10-K · filed 2017-11-22 | $409.00M derived: sum of 2 quarters · filed 2017-11-22 | $747.00M derived: sum of 3 quarters · filed 2017-11-22 | $976.00M 10-K · filed 2018-11-21 |
| 2016-06-30 | $390.00M 10-K · filed 2017-11-22 | $728.00M derived: sum of 2 quarters · filed 2017-11-22 | $958.00M 10-Q · filed 2017-08-03 | $1.14B derived: sum of 4 quarters · filed 2017-11-22 |
| 2016-03-31 | $338.00M 10-K · filed 2017-11-22 | $567.00M 10-Q · filed 2017-05-02 | $748.00M derived: sum of 3 quarters · filed 2017-11-22 | $810.00M derived: sum of 4 quarters · filed 2017-11-22 |
| 2015-12-31 | $229.00M 10-K · filed 2017-11-22 | $410.00M derived: sum of 2 quarters · filed 2017-11-22 | $472.00M derived: sum of 3 quarters · filed 2017-11-22 | $688.00M derived: sum of 4 quarters · filed 2017-11-22 |
| 2015-09-30 | $181.00M 10-K · filed 2016-11-23 | $243.00M derived: sum of 2 quarters · filed 2016-11-23 | $459.00M derived: sum of 3 quarters · filed 2016-11-23 | $695.00M 10-K · filed 2017-11-22 |
| 2015-06-30 | $62.00M 10-K · filed 2016-11-23 | $278.00M derived: sum of 2 quarters · filed 2016-11-23 | $514.00M 10-Q · filed 2016-08-04 | $815.00M derived: sum of 4 quarters · filed 2016-11-23 |
| 2015-03-31 | $216.00M 10-K · filed 2016-11-23 | $452.00M 10-Q · filed 2016-05-06 | $753.00M derived: sum of 3 quarters · filed 2016-11-23 | $1.08B derived: sum of 4 quarters · filed 2016-11-23 |
| 2014-12-31 | $236.00M 10-K · filed 2016-11-23 | $537.00M derived: sum of 2 quarters · filed 2016-11-23 | $863.00M derived: sum of 3 quarters · filed 2016-11-23 | $1.15B derived: sum of 4 quarters · filed 2016-11-23 |
| 2014-09-30 | $301.00M 10-K · filed 2015-11-25 | $627.00M derived: sum of 2 quarters · filed 2015-11-25 | $914.00M derived: sum of 3 quarters · filed 2015-11-25 | $1.19B 10-K · filed 2016-11-23 |
| 2014-06-30 | $326.00M 10-K · filed 2015-11-25 | $613.00M derived: sum of 2 quarters · filed 2015-11-25 | $884.00M 10-Q · filed 2015-08-06 | $974.00M derived: sum of 4 quarters · filed 2015-11-25 |
| 2014-03-31 | $287.00M 10-K · filed 2015-11-25 | $558.00M 10-Q · filed 2015-05-08 | $648.00M derived: sum of 3 quarters · filed 2015-11-25 | $950.00M derived: sum of 4 quarters · filed 2015-11-25 |
| 2013-12-31 | $271.00M 10-K · filed 2015-11-25 | $361.00M derived: sum of 2 quarters · filed 2015-11-25 | $663.00M derived: sum of 3 quarters · filed 2015-11-25 | |
| 2013-09-30 | $90.00M derived: 10-K 12 month − 10-Q 9 month · filed 2015-11-25 | $392.00M derived: sum of 2 quarters · filed 2015-11-25 | $1.29B 10-K · filed 2015-11-25 | |
| 2013-06-30 | $302.00M 10-Q · filed 2014-08-04 | $1.20B 10-Q · filed 2014-08-04 | ||
| 2012-09-30 | $1.17B 8-K · filed 2015-03-13 | |||
| 2010-03-31 | $297.63M 10-Q · filed 2010-05-06 | $614.01M 10-Q · filed 2010-05-06 | $931.23M derived: sum of 3 quarters · filed 2010-05-06 | $1.27B derived: sum of 4 quarters · filed 2010-05-06 |
| 2009-12-31 | $316.38M 10-Q · filed 2010-02-08 | $633.60M derived: sum of 2 quarters · filed 2010-02-08 | $974.62M derived: sum of 3 quarters · filed 2010-02-08 | $1.24B derived: sum of 4 quarters · filed 2010-05-06 |
| 2009-09-30 | $317.22M derived: 10-K/A 12 month − 10-Q 9 month · filed 2010-01-21 | $658.25M derived: sum of 2 quarters · filed 2010-01-21 | $919.54M derived: sum of 3 quarters · filed 2010-05-06 | $1.23B 10-K/A · filed 2010-01-21 |
| 2009-06-30 | $341.03M 10-Q · filed 2009-08-10 | $602.32M derived: sum of 2 quarters · filed 2010-05-06 | $914.38M 10-Q · filed 2009-08-10 | $1.20B derived: sum of 4 quarters · filed 2010-05-06 |
| 2009-03-31 | $261.29M 10-Q · filed 2010-05-06 | $573.36M 10-Q · filed 2010-05-06 | $855.53M derived: sum of 3 quarters · filed 2010-05-06 | $1.15B derived: sum of 4 quarters · filed 2010-05-06 |
| 2008-12-31 | $312.07M 10-Q · filed 2010-02-08 | $594.24M derived: sum of 2 quarters · filed 2010-02-08 | $891.33M derived: sum of 3 quarters · filed 2010-02-08 | |
| 2008-09-30 | $282.18M derived: 10-K/A 12 month − 10-Q 9 month · filed 2010-01-21 | $579.26M derived: sum of 2 quarters · filed 2010-01-21 | $1.13B 10-K/A · filed 2010-01-21 | |
| 2008-06-30 | $297.09M 10-Q · filed 2009-08-10 | $844.82M 10-Q · filed 2009-08-10 | ||
| 2007-09-30 | $890.03M 10-K/A · filed 2010-01-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| BOSTON SCIENTIFIC CORP (BSX) | United States | $64.781B | 17.29 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |